This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions CI
Transcript : Thermo Fisher Scientific Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal RE
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip RE
Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540 MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing MT
HSBC Raises Thermo Fisher Scientific's Price Target to $670 From $660 MT
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific CI
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615 MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600 MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644 MT
Bernstein Adjusts Thermo Fisher Scientific Price Target to $553 From $544 MT
JPMorgan Adjusts Thermo Fisher Scientific Price Target to $650 From $600 MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $650 From $620, Keeps Overweight Rating MT
Stifel Adjusts Price Target on Thermo Fisher Scientific to $600 From $595 MT
Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $640 MT
Barclays Adjusts Price Target on Thermo Fisher Scientific to $615 From $590 MT
RBC Adjusts Price Target on Thermo Fisher Scientific to $662 From $657 MT
Wolfe Research Raises Thermo Fisher Scientific's Price Target to $625 From $615 MT
Baird Trims Thermo Fisher Scientific's Price Target to $620 From $621 MT
Chart Thermo Fisher Scientific
More charts
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
599 USD
Average target price
627.3 USD
Spread / Average Target
+4.72%
Consensus
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. News Thermo Fisher Scientific
  5. Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW